Search

ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology

Press release

Key updates

September 21, 2017
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update

Press release

Key updates

February 28, 2017
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences

Press release

… Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the … October 8 – 10, 2015 and the 11 th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Leiden, The Netherlands, October 11 – 14, …

October 01, 2015
ProQR to Present at Scientific and Investor Conferences in September

Press release

LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

September 06, 2016
ProQR Announces Presentations at the OTS Annual Meeting

Press release

LEIDEN, the Netherlands, Sept. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

September 24, 2018
ProQR Announces Financial Results for the Third Quarter of 2018

Press release

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 07, 2018
ProQR Announces Results for the Third Quarter of 2016

Press release

LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

November 14, 2016
ProQR Announces Results for the Third Quarter of 2017

Press release

… interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on central … Axiomer ® RNA editing technology platform at the Oligonucleotide Therapeutics Society (OTS) meeting in Bordeaux, France and at the Drug …

November 20, 2017